Trecondi Uses, Dosage, Side Effects and more
Trecondi is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Trecondi has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.
Trade Name | Trecondi |
Generic | Treosulfan |
Treosulfan Other Names | DIHYDROXYBUSULFAN, OVASTAT, Treosulfan |
Type | infusion |
Formula | C6H14O8S2 |
Weight | Average: 278.29 Monoisotopic: 278.013009759 |
Groups | Approved, Investigational |
Therapeutic Class | |
Manufacturer | medac GmbH |
Available Country | United Kingdom |
Last Updated: | January 7, 2025 at 1:49 am |